Biotechnology Could This Common Virus Unlock New Cancer Treatments? Theriva Biologics Believes That Adenoviruses Could Be Instrumental In The Next Evolution Of Oncology – Candel Therapeutics (NASDAQ:CADL), CG Oncology (NASDAQ:CGON) Read more
Biotechnology Pfizer’s Respiratory Syncytial Virus Vaccine Maintains Staying Power In Older Adults Through 2nd RSV season, Study Finds – Pfizer (NYSE:PFE) Read more